At a ceremony on September 8, Ropes & Gray was honored with five LMG Life Sciences Americas Awards for 2022.
Ropes & Gray was awarded “Government Investigations Firm of the Year,” “M&A Firm of the Year” and “Life Cycle Firm of the Year – United States.”
In addition, mergers & acquisitions partner Emily Oldshue was named “U.S. Rising Star–Financial & Corporate.”
The firm was also honored in the category of “Impact Deals of the Year” for advising Pfizer in its $11.6 billion acquisition of Biohaven Pharmaceuticals. Led by Emily Oldshue, the Biohaven transaction features the acquisition by Pfizer of Biohaven’s migraine and calcitonin gene-related peptide (CGRP) programs, including Nurtec ODT and zavegepant, following a pre-closing spin-off of Biohaven’s non-CGRP programs into a new public company.
The LMG Life Sciences Awards honor top-ranking firms and individuals for outstanding life sciences legal work in practice areas including regulatory, intellectual property, financial and corporate, and litigation and enforcement.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.